Roswell Biotechnologies, Inc.
Roswell Biotechnologies, Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in advanced genomic sequencing technologies. Founded in 2016, Roswell has rapidly established itself as a leader in the development of innovative solutions for DNA and RNA analysis, catering to both research and clinical applications. The company’s flagship product, the Roswell Biotechnologies’ platform, offers unique capabilities in high-throughput sequencing, enabling researchers to conduct comprehensive genomic studies with unprecedented accuracy and efficiency. With a commitment to advancing personalised medicine, Roswell Biotechnologies has achieved significant milestones, including collaborations with major research institutions and recognition for its contributions to the field. As a key player in the biotechnology landscape, Roswell Biotechnologies continues to drive innovation, positioning itself at the forefront of genomic research and diagnostics.
DitchCarbon Score
How does Roswell Biotechnologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roswell Biotechnologies, Inc.'s score of 26 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roswell Biotechnologies, Inc.'s reported carbon emissions
In 2015, Roswell Biotechnologies, Inc. reported total carbon emissions of approximately 373,836,000 kg CO2e. This figure includes about 49,333,000 kg CO2e from Scope 1 emissions and approximately 324,503,000 kg CO2e from Scope 2 emissions. The previous year, 2014, the company’s total emissions were about 398,118,000 kg CO2e, with Scope 1 emissions at approximately 49,369,000 kg CO2e and Scope 2 emissions at around 348,749,000 kg CO2e. Despite these figures, Roswell Biotechnologies has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. There are no commitments to the Science Based Targets initiative (SBTi) or other climate pledges noted in the available data. The emissions data is not cascaded from any parent or related organization, indicating that Roswell Biotechnologies is independently reporting its emissions. The company has disclosed emissions for Scope 1 and Scope 2 but has not provided data for Scope 3 emissions. Overall, while Roswell Biotechnologies has made strides in transparency regarding its emissions, further commitments and reduction strategies would be beneficial for enhancing its climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | |
|---|---|---|
| Scope 1 | 49,369,000 | 00,000,000 |
| Scope 2 | 348,749,000 | 000,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roswell Biotechnologies, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
